Celltrion Accelerates Development of Novel First-in-Class Therapy for Obesity, Diabetes, and Metabolic Disorders, Aiming for Next-Year IND...
Drug
Image: Park Bom’s SNS Park Bom, a member of the iconic K-pop girl group 2NE1, has captured...
Yuhan Corp.’s main research center (Yuhan Corp.) Yuhan Corporation announced Monday that its investigational therapy, YH35995, has...
JW Group Chairman Lee Kyung-ha (right) and Gan & Lee Pharmaceuticals CEO Wei Chen pose for a...
LG Chem LG Chem is bolstering its efforts to develop groundbreaking cancer treatments by targeting previously “undruggable”...
Sam Chun Dang Pharm CEO Chun In-seok (Sam Chun Dang Pharm) Sam Chun Dang Pharm is making...
Ignis Therapeutics SK Biopharmaceuticals officially launched Cenobamate, its innovative epilepsy medication, in China on Thursday, signaling a...
Seo Jin-seok (right), executive vice president of Celltrion, and Ko Kwang-pyo, CEO of KoBioLabs, pose for a...
(Samsung Bioepis) Samsung Bioepis and Epis NexLab, subsidiaries of Samsung Epis Holdings, have announced a strategic joint...
Nam Tae-hyun, former member of WINNER, leaves the Seoul Western District Court after receiving a prison sentence...